Navigating Novel Cannabinoid Regulatory Pathways During Preclinical & Clinical Research
Time: 1:45 pm
day: Conference Day 1
Details:
- What unique challenges does the industry face when complying with regulations related to novel cannabinoids?
- What can we learn from previous cannabinoid drug approvals to aid the acceleration of new approvals?
- How do we address chemical and biological contaminants in cannabinoid products while adhering to regulations
- What recent advancements of analytical methodology can we take advantage of to comply with regulatory guidelines?
- How do FDA, USP, and ASTM regulations intersect and diverge concerning cannabinoids?
